PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-27

  1. 52 Posts.
    lightbulb Created with Sketch. 15
    Thank you for taking the time to reply message2ben. .I appreciate the details you have provided about the credit raise. It's obvious to me now that I have been very naive when reading articles like the one I quoted about both PAR and other stocks. I will heed your advice and spend more time using Hotcopper to inform any decisions I make.Very grateful for your help.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.